Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID‐19

by Nathan D. Pfeifer, Arthur Lo, David L. Bourdet, Kenneth Colley, Dave Singh
Published 2021